Download
U.S. FDA approves Moderna and J&J boosters, 'mix-and-match' strategy
CGTN

The U.S. Food and Drug Administration (FDA) on Wednesday authorized booster doses of the COVID-19 vaccines from Moderna Inc and Johnson & Johnson, and said Americans can choose a different shot than their original inoculation as a booster.

The decision paves the way for millions more people in the U.S. to get the additional protection with the highly contagious Delta variant of the virus causing breakthrough infections among some who are fully vaccinated.

The agency previously authorized boosters of the Pfizer Inc COVID-19 vaccine developed with German partner BioNTech SE at least six months after the first round of shots to increase protection for people aged 65 and older, those at risk of severe disease and those who are exposed to the virus through their work.

Source(s): Reuters

Search Trends